Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

FHS
May 7, 2024
10:38 am

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary.

‘Minimal’ Benefit Seen With Antibiotics for Acute Sinusitis in Kids

Antibiotic treatment provided “minimal” benefit for children with acute sinusitis and was accompanied by more cases of clinically significant diarrhea, researchers reported. In a randomized

July 26, 2023

A paramedic was skeptical about this Rx for stopping repeat opioid overdoses. Then he saw it help.

Fire Capt. Jesse Blaire steered his SUV through the mobile home park until he spotted the little beige house with white trim and radioed to

March 25, 2024

New oral peptide therapy offers hope for chronic abdominal pain

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral peptide therapeutic leads for

November 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.